SubscribeLogin
dermatologytimes.com image

News from dermatologytimes.com

We’ve assigned a rating of Unknown factuality to dermatologytimes.com. You can read more about how we’ve determined dermatologytimes.com’s credibility and reliability as a news source here: https://ground.news/rating-system.

Information about dermatologytimes.com

Where is dermatologytimes.com located?dermatologytimes.com's Website

Media Bias Ratings

Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.

Factuality

Average Factuality Rating:
Learn more about Factuality Ratings.

Top dermatologytimes.com News

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria - Regeneron Pharmaceuticals (NASDAQ:REGN)
United States · United States

Press Release: Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria - Regeneron Pharmaceuticals (NASDAQ:REGN)

100% Center coverage: 1 sources
Dupixent sBLA accepted for FDA review for the treatment of chronic spontaneous urticaria Resubmission includes new pivotal data which confirm Dupixent significantly reduced itch and hive activity More than 300,000 people in the US suffer from chronic spontaneous urticaria (CSU) that is inadequately controlled by antihistamines FDA decision expected by April 18, 2025; if approved, Dupixent would be the first targeted therapy for CSU in a decade…See the Story
Day 4 Recap: SDPA Fall 2024
Las Vegas, Nevada · Las Vegas

Day 4 Recap: SDPA Fall 2024

Catch up on coverage from the final day of the 2024 Society of Dermatology Physician Associates Fall Conference in Las Vegas, Nevada.See the Story
Advances and Challenges in Rosacea Treatment: Insights From Hilary Baldwin, MD
Maryland · Maryland

Advances and Challenges in Rosacea Treatment: Insights From Hilary Baldwin, MD

At the 2024 SDPA Fall Conference, Hilary Baldwin, MD, highlighted innovative strategies for managing complex rosacea cases, the importance of combination approaches, and a slowing treatment pipeline.See the Story

Latest News Stories

You've scrolled to the bottom of the feed, there are no more stories.
Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal